Por: MarketWatch Politics January 09, 2023
Moderna provided the update in advance of the company’s presentation at the annual J.P. Morgan Healthcare Conference in San Francisco. Separately, CureVac said preliminary data from its early stage trial for its COVID and seasonal flu shots had positive results to advance to the next stage of clinical testing. CureVac is developing the shots with GlaxoSmithKline . CureVac said the shot was well tolerated, and that neutralizing... + full article
RTTNews USA Health January 09, 2023
Ocugen () reported positive results from the Phase 2/3, observer-blind, immuno-bridging and broadening study of its COVID-19 vaccine candidate, COVAXIN. The study met both co-primary endpoints with robust immune responses. COVAXIN has been demonstrated in clinical trials to... + más
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government's pandemic response | MarketWatch
Will Ascendis End The Year On A High Note? | RTTNews
CNBC USA Health December 06, 2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
Forbes USA Business November 29, 2022
Getty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
The Verge USA Health September 24, 2022
Moderna is suing Pfizer over its coronavirus vaccineModerna is suing Pfizer over its coronavirus vaccine / The company is filing patent infringement lawsuits against Pfizerp>span:first-child]:text-black text-blurple>By Aug 26, 2022, 12:37 PM UTC Share this story... + más
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
Los Angeles Times USA Nation September 24, 2022
As residents prepare to roll up their sleeves for a third, fourth or even fifth dose of COVID-19 vaccine, some may be wondering: Do I need to stick with the same brand, or is it safe to mix it up? When it comes to the new COVID-19 Omicron bivalent booster, the answer is, yes,... + más
PennLive USA Nation September 24, 2022
By Luke Money and Rong-Gong Lin II, Los Angeles TimesLOS ANGELES — As residents prepare to roll up their sleeves for a third, fourth or even fifth dose of COVID-19 vaccine, some may be wondering: Do I need to stick with the same brand, or is it safe to mix it up?When it comes... + más
About iurex | Privacy Policy | Disclaimer |